etoposide has been researched along with Granulomatosis with Polyangiitis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jensen, DM; Pedersen, RS | 1 |
Bistrup, C; Pedersen, RS | 1 |
Bletry, O; Godeau, P; Le Thi Huong, D; Papo, T; Piette, JC; Wechsler, B; Wiederkehr, JL; Woehl-Kremer, B | 1 |
Lanyon, PC; Morton, SJ; Powell, RJ | 1 |
D'Cruz, D; Hughes, GR; Payne, H; Timothy, A | 1 |
5 other study(ies) available for etoposide and Granulomatosis with Polyangiitis
Article | Year |
---|---|
Etoposide: sometimes the drug of choice in Wegener's granulomatosis?
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Antineoplastic Agents, Phytogenic; Autoantibodies; B-Lymphocytes; Etoposide; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Plasma Exchange | 1995 |
Etoposide: more effective and less bone-marrow toxic than standard immunosuppressive therapy in systemic vasculitis?
Topics: Adolescent; Adult; Bone Marrow; Etoposide; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppression Therapy; Male; Remission Induction; Vasculitis | 1996 |
Etoposide in Wegener's granulomatosis.
Topics: Adult; Antineoplastic Agents, Phytogenic; Etoposide; Female; Granulomatosis with Polyangiitis; Humans; Male; Middle Aged | 1999 |
Etoposide in Wegener's granulomatosis.
Topics: Adult; Etoposide; Female; Granulomatosis with Polyangiitis; Humans; Male; Middle Aged; Treatment Outcome | 2000 |
Response of cyclophosphamide-resistant Wegener's granulomatosis to etoposide.
Topics: Cyclophosphamide; Drug Resistance, Microbial; Etoposide; Granulomatosis with Polyangiitis; Humans; Male; Middle Aged | 1992 |